
ããã¯ã©ãã¹ã®ç²ç¹ ããŒã1ïŒãå°æ°ã®ç ç²ã¯ä»æ¹ãªãããšããèšèã®èŽåœçç²ç¹
ãå»çã«ãããŠæãéèŠãªæåŸã¯ãäœããããŸãæ£è ã«å®³ãäžããªãããšã§ããããªããªããåè¡ãæœãããšããŠå®³ãå ããããšã¯ãå»è¡ãã®ãã®ãåŠå®ããããšã ããã ã
ã¯ããã«
æ ç»é€šãåºãåŸããããèšèãé ããé¢ããªãã£ããããªã¹ã¯ããããããã£ãããäžåãã®ã§ããã°ããããåãå ¥ããæ¹ãè¯ããââç»é¢ã«ç»å Žããå°éå®¶ããæ·¡ã ãšããèªã£ãŠããããã®åå©äž»çŸ©çãªèšç®ã¯ããã€ããå»çã®åºæ¬ååã®ããã«ãªã£ãã®ã ããããå»åŠã®ç¥ããã¯ã©ãã¹ã2500幎åã«å®ãããäœããããŸãã害ããªããªããããšããèªãã¯ãã©ããžæ¶ããã®ãã
æ ç»ãããã¯ã©ãã¹ã®ç²ç¹ãã¯ããã®ååãäœåºŠãç»é¢ã«æ ãåºãããããããå€ãã®èŠ³å®¢ã¯æ ¹æ¬çãªçåãæ±ãããŸãŸåå ŽãåŸã«ããã®ã§ã¯ãªãã ãããããªãããŸãã害ãå ããŠã¯ãããªãã®ãããªãã5人ãæãããã«1人ãç ç²ã«ããããšããèšç®ããå»çã«ãããŠèš±ãããªãã®ãããã®çãã¯ããªã¹ã¯ãããã£ããè«ãèŠèœãšããŠãããããæ·±ããå«ççåºç€ãã«ããã
æ¬èšäºã§ã¯ãæ»èªè«æãMedical Ethics and the Trolley Problemããæãããã«ãéå±å®³ååïŒå®³ãå ããªãããšïŒããªããªã¹ã¯ãããã£ããèšç®ã«åªå ãããã¹ããªã®ããè§£ãæããã
è«æçŽ¹ä»
æ¬èšäºã®äž»èŠãªåèæç®ã¯ãã¬ããªãšã«ã»ã¢ã³ãã©ãŒãïŒGabriel AndradeïŒã«ããæ»èªè«æãMedical Ethics and the Trolley ProblemãïŒJournal of Medical Ethics and History of Medicine, 2019ïŒã§ãããæ¬è«æã§ã¯ããã£ãªããã»ãããã1967å¹Žã«æå±ãããããã³åé¡ãå»çå«çã®æèã§åæ€èšããŠããã
ãåç¥ã®æ¹ãå€ããšæããããããã³åé¡ãšã¯ãæŽèµ°ãããããã³ã5人ã®äœæ¥å¡ã«åãã£ãŠé²ãã§ããæãã¬ããŒãåŒããŠå¥ã®ç·è·¯ã«åãæ¿ããã°1人ã ããç ç²ã«ãªãââãã®ç¶æ³ã§äœããã¹ãããåãæèå®éšã ãæ¬è«æã¯ããã®å€å žçãžã¬ã³ãã®ããã€ãã®ããŒãžã§ã³ãéããŠãéå±å®³ååããªãä»ã®å«çååãããåªå ãããã¹ãããæ€èšŒããã

ãªãä»ãã®è«æãåãäžããã®ãããã³ãããã¯ããããæããä»ãã¯ã¯ãã³ãæã£ãå€ãã®äžè¬äººããããªã¹ã¯ãšãããã£ããããšããèšèãæŸã€ããã«ãªããã倿°ãæãããã®å°æ°ç ç²ã¯ä»æ¹ãªãããšããåå©äž»çŸ©ã®èããã絶察èŠããé¢šæœ®ã«æãŸã£ãŠãããæŽå²ãå»çå«çãç¥ããªãäžè¬äººããããã¯ã©ãã¹ã®èªãããååãã§ã¯ãªãåãªãå«ççãèŠåãã ãšèããŠããŸãã®ã¯ã仿¹ãªãé¢ãããã
ã ããå»çã®å°éå®¶ããããå€å°ã®ç ç²ã¯é¿ããããªãããšããïŒäºéã®æå³ã§ééã£ãïŒçºèšãæŒãèãããããã«ãªã£ãŠãããããã°ããããçåœå«çåŠè ããã®æ¹å€ã®å£°ãèãããŠããªãââ瀟äŒå šäœã§å»çå«çã®åºç€ãã²ããŠã¯å«çãã®ãã®ãæºããå§ããŠããã®ã§ã¯ãªããããããªå±æ©æããæ ç»ãããã¯ã©ãã¹ã®ç²ç¹ãã芳ãåŸã«è¥²ããããããããä»ãæžããããåŸãªãçç±ã ã
èåšç§»æ€ã®ãžã¬ã³ãïŒãªã1äººãæ®ºããŠ5人ãæãããšã¯èš±ãããªãã®ã
ãå«çç倿ã«ãããŠæ°ãæ°ããããšã¯ããã°ãã°äººéã®å°å³ãæ°ããããšãå¿ããããã
ããå€ç§å»ã®ããšã«ãèåšç§»æ€ãåŸ ã€5人ã®çæ»ã®æ£è ãããããã®æãå¥åº·ãªè¥ãæ è¡è ã宿æ€èšºã«ãã£ãŠãããå»åž«ã¯æ°ã¥ãââãã®æ è¡è ã®èåšã¯å®ç§ã«5人ãšé©åãã圌ãå§¿ãæ¶ããŠã誰ãå»åž«ãšçµã³ã€ããªããå»åž«ã¯æ è¡è ãæ®ºããŠèåšãåé ãã¹ããã

ãªã¹ã¯ãããã£ããã«åºã¥ããªãããã®ç·æ§ã殺ããŠèåšãåé ãã¹ãã§ããããªããšãã£ãŠãäžäººã殺ããŠ5人ã®åœãå©ããã®ã ããïŒ
âŠèšããŸã§ããªããå§åç倿°ããèš±ãããªãããšçãããããã¯ããªãã
çãã¯ããã¯ã©ãã¹ã®èªãã§ããããéå±å®³ååãã®åªäœæ§ã«ãããããšã5人ãæãããšããŠãããå¥åº·ãªã1äººãæ®ºãããšã¯ãå»åž«ã®æãæ ¹æ¬çãªçŸ©åââ害ãåãŒããªããšãã矩åââã«åãããå»åž«ã5äººãæ»ãªããããšã¯äžäœçºã«ããæ»ã§ãããçŽæ¥çã«å®³ãå ããŠããããã§ã¯ãªããããããæ è¡è ãæ®ºãããšã¯äœçºã«ããæ®ºäººã§ãããæç¢ºãªå±å®³ã§ããã
ãã£ãªããã»ãããã«ããã°ããæ¶æ¥µç矩åãïŒïœãããªã矩åïŒã¯ãç©æ¥µç矩åãïŒïœããã矩åïŒãããåªå ããããæ è¡è ãæ®ºããªã矩åã¯ã5äººã®æ£è ãæã矩åããã匷ãããããå»çå«çã®æ ¹å¹¹ããªããå»åž«ãæ£è ã«å®³ãåãŒããªã矩åã¯ããã¹ãŠã®åè¡ã®çŸ©åã«å ç«ã€ã
https://t.co/6tJp4ZP7O8
â Alzhacker (@Alzhacker) October 23, 2021
ãããã³åé¡ã§ã5人ãæãããã«1äººãæ®ºãããšã¯å«ççã«èš±ãããããã«æããã
ç§»æ€ã®å ŽåãèããŠã¿ãããå€ç§å»ã¯ãç é¢ã«çŸããå¥åº·ãªäžäººãšããã®èåšã§æ²»ãã5äººã®æ«ææ£è ãããã°ããã®äººã¯æ®ºãããã¹ããªã®ãïŒ
ãããã³åé¡ã®æ žå¿ïŒé転æãšå芳è ã®æ±ºå®çãªéã
ãåå©äž»çŸ©ã®å±éºæ§ã¯ãåäººãææ®µãšããŠæ±ãããšãæ£åœåãããããŠèª°ããç ç²ã®åè£ã«ãªããããšããææã瀟äŒã«æ€ãä»ããããšã«ããã
ãããããããèªèº«ãèªããŠããããã«ãã1äººãæ®ºããŠ5人ãæããããšãåžžã«äžæ£ãšããããã§ã¯ãªãã
ã±ãŒã¹1ïŒé転æïŒïŒæŽèµ°ãããããã³ã®é転æã¯ã5人ãçžãããç·è·¯ãã1人ãçžãããç·è·¯ã®ã©ã¡ãããéžã°ãªããã°ãªããªããå€ãã®äººãã1人ã®ç·è·¯ã«åãæ¿ããã¹ãããšçããã
ã±ãŒã¹2ïŒå芳è ïŒïŒä»åºŠã¯å芳è ãã¬ããŒãåŒããŠåãæ¿ãããããé©ãã¹ãããšã«ããã®ã±ãŒã¹ã§ãå€ãã®äººããã¬ããŒãåŒãã¹ãããšçããã
é転æã®ã±ãŒã¹ã§ã¯ã1äººãæ®ºã vs. 5äººãæ®ºããã ããå芳è ã®ã±ãŒã¹ã§ã¯ã1äººãæ®ºã vs. 5äººãæ»ãªãããââæ§é çã«ã¯èåšç§»æ€ãšåãã ããªããã®éããçããã®ãã
ãã ãœã³ã®èª¬æã¯ãã«ã³ãå«çåŠã«ããããäººãææ®µãšããŠæ±ããªããååã«äŸæ ãããèåšç§»æ€ã§ã¯ãæ è¡è ã¯5人ãæãããã®ãææ®µããšããŠå©çšããããããæ è¡è ãéããã°ãèšç»ã¯åŽ©å£ããããããããããã³ã®ã±ãŒã¹ã§ã¯ãå¥ã®ç·è·¯ã®1äººã¯ææ®µã§ã¯ãªãçµæãšããŠçãããäžå¹žãªçµæããšã¿ãªãããã圌ãããªããŠãïŒããªããšããè«ççæ³å®ãããŠãïŒ5äººã¯æãããã
ãã®åºå¥ããéå±å®³ååã®é©çšã«ãããŠæ±ºå®çã«éèŠãšãªãã
äºé广ã®ååïŒæå³ãšäºèŠã®æ±ºå®çãªéã
ãäºèŠãšæå³ã®åºå¥ã¯ãé埳çè²¬ä»»ã®æ žå¿ã§ããã
ããã§çŸå®ã®å»çåé¡ââã¯ã¯ãã³æ¥çš®ââãèããããã¯ã¯ãã³ãäžå®æ°ã®æå®³äºè±¡ãåŒãèµ·ããããšã¯äºå®ã ãå³å¯ã«èšãã°ãæ¥çš®è ã¯ãå°æ°ã殺ã vs. 倿°ãæ»ãªããããšãããžã¬ã³ãã«çŽé¢ããŠãããéå±å®³ååãè«ççã«é©çšããã°ãã¯ã¯ãã³ã¯çŠæ¢ãããããšã«ããã
ããããçè«çã«ã¯ãäºé广ã®ååïŒdoctrine of double effectïŒããã®ççŸã解決ãããšããããããŒãã¹ã»ã¢ã¯ã£ãã¹ãå®åŒåãããã®ååã«ããã°ãããè¡çºãåãšæªã®äž¡æ¹ã®å¹æãæã€å Žåã以äžã®æ¡ä»¶ãæºããã°èš±å®¹ãããïŒ
è¡çºèªäœãé埳çã«åãŸãã¯äžç«ïŒã¯ã¯ãã³æ¥çš®ã¯ãç æ°ãé²ãæ£åœãªå»çè¡çºã ïŒ
æªã广ãåãå¹æã®ææ®µã§ã¯ãªãïŒæ»ã¯æåœã®ææ®µã§ã¯ãªããé¿ãããå¯äœçšã ïŒ
è¡çºè ã®æå³ã¯åã广ã®ã¿ã«ããïŒå»åž«ãã¯ææé²æ¢ãæå³ããå¯äœçšæ»ãæãã§ããªãïŒ
åãå¹æãæªã广ããã倧ããïŒæãããåœããå¯äœçšæ»ãäžåãïŒ
ã¯ã¯ãã³æ¥çš®ã¯ããããã®æ¡ä»¶ãæºãããšãããŠãããå°æ°ã®æ»ã¯å€æ°ã®æåœã®ææ®µã§ã¯ãªããæ¥çš®è ã¯æ»ãæå³ãããæãããåœã¯å€±ãããåœãäžåãããããã£ãŠãã¯ã¯ãã³ã«ãã害ã¯äºèŠããããæå³ãããªãå¯äœçšãšããŠèš±å®¹ããããšããã®ãã¯ã¯ãã³æ£åœåã®è«çã ã
æ ç»ã«ãŠããããŸã§ã®ä»ã®ã¯ã¯ãã³ã§ããã°ãã¯ã¯ãã³æ¥çš®ãšé¢é£ããæ»äº¡ã10äžä»¶ã«0.5ä»¶ã§ãã£ãŠããåé¡èŠããããšããã·ãŒã³ãæµããããªããããªã®ããšãã説æãæãèœã¡ãŠãããããåã«ã¯ã¯ãã³å»çã§ã¯äŒçµ±çã«ããã§ãã£ããšããçè§£ã«ãšã©ãŸã£ãŠãããããã§ã¯ãªãããã®ãããªäœãèŽæ»çãç®æãããšã¯ãäºé广ã®ååããæºããããã«å¿ èŠãªåªåãªã®ã ã
ãããŠãCOVID-19ãã³ãããã¯ã«ãããmRNAã¯ã¯ãã³ã®ç·æ¥å±éã¯ãããããèŠãŠããããã«ããããã®4æ¡ä»¶ãæããã«æºãããŠããªãã£ãå¯èœæ§ãé«ãã
ãã³ãããã¯ãæŽããççŸïŒã¯ã¯ãã³ã¯ãäºé广ã®ååããæºãããã®ã
ãç·æ¥äºæ ãšããåç®ã§å«çååãäžæåæ¢ãããæãããã¯ãã°ãã°æ°žç¶çãªæš©å©å¥å¥ªã®å§ãŸãã§ããã
ãžã§ã«ãžã§ã»ã¢ã¬ã³ãã³ïŒãäŸå€ç¶æ ãããïŒ
çè«äžãã¯ã¯ãã³ã¯äºé广ã®ååã«ãã£ãŠæ£åœåã§ããããããããã³ãããã¯äžã®ã¯ã¯ãã³å±éã¯ã以äžã®ç¹ã§æ·±å»ãªçåãæ®ããã
1. è¡çºèªäœããåãäžç«ããïŒ ââæ¥ããããã®ãå®éšãã ã£ã
ã¯ã¯ãã³æ¥çš®ã¯ãç æ°ãé²ãå»çè¡çºãšããŠäžç«ã®ã¯ãã ãã ããmRNAæè¡ã¯æ°ããã£ããåŸæ¥ã®ã¯ã¯ãã³éçºã¯æ°å¹Žãããã®ã«ãCOVID察å¿ã§ã¯æ°ã¶æã§ç·æ¥äœ¿çšèš±å¯ïŒEUAïŒãåºããé·æã®å®å šæ§ãã¹ããã¹ãããããäžçäžã®äœå人ãã«æãããã®ã ãããã¯ãæ²»çãã§ã¯ãªãã巚倧ãªäººäœå®éšã«è¿ãã£ãã
2025幎9æã®CDCå ±åæžã§ããmRNAã¯ã¯ãã³ã®å ç«å€åã®åœ±é¿ããäžç¢ºå®ãã ãšèªãããããªãç ç©¶ãæ±ããŠãããæ ç»ã§ãèªãããŠããããã«ãæªç¥ã®é·æå¯äœçšââå¿èççãèªå·±å ç«çŸæ£ã®ãªã¹ã¯ââãç¡èŠããè¡çºã¯ãé埳çäžç«æ§ã倱ãã被éšè ãå®ãã¯ãã®å«çã«ãŒã«ïŒãã«ã·ã³ã宣èšïŒãèžã¿ã«ãã£ãã®ã ã
2. æªã圱é¿ã¯ãææ®µããããªãïŒ ââæ¯ãè¬ã®ãäžéšãã«
mRNAã¯ã¯ãã³ã¯ãäœå ã§ã¹ãã€ã¯ã¿ã³ãã¯è³ªãäœãããŠå ç«ã掻æ§åãããåã广ã ãã ãããã®ã¿ã³ãã¯è³ªèªäœãæ¯æ§ãæã¡ãè¡ç®¡ãå·ã€ãççãèµ·ãããæªã广ïŒå¿ççãè¡æ ïŒããå ç«èªå°ã®ãææ®µããšããŠäžå¯é¿çã«ãã£ã€ããŠããã®ã ãç ç©¶ã§ã¯ãã¹ãã€ã¯ã®æ¯æ§ãå ç«ã®å¯ç£ç©ã§ã¯ãªããä»çµã¿ã®æ žå¿ã ãšææãããŠãããé¿ããããªããªããããã¯å¯äœçšãããªããèšèšã®æ¬ é¥ã ãäºé广ã®ååã¯ãææ®µã®åé¢ããæ±ããã®ã«ãããã§ã¯å®³ãåã®ãšã³ãžã³ãã®ãã®ãšãªã£ãŠãããäºèŠãããã©ããããæå³çã«çµã¿èŸŒãŸããæ¯ââãããã仿¹ãªãããšåŒã¶ããšã¯äžå¯èœã ã
3. åãå¹æãæ¬åœã«æå³ããã®ãïŒå©çãšãããã¬ã³ãã®åœ±
åœå±ã補è¬äŒç€Ÿã®æ¬åœã®æå³ã¯ãææé²æ¢ã ãšèšããã ããããŒã¿æäœã®çæãçµ¶ããªããèšåºè©Šéšã§å¯äœçšãé èœããæå¹æ§ã95%ãšå€§ããã«å®£äŒãããæªå ¬éã®çäŸãé€å€ããå©ççžåã®æžŠäžã§EUAãæ¥ãã ã®ã ã2025幎çŸåšãå°éå®¶ãã¡ã¯ãCOVIDã¯ã¯ãã³çŸ©ååãžã®è¬çœªããæ±ããmRNAã¯ã¯ãã³ã«ã°ããŒãã«ãªäœ¿çšåæ¢ãåŒã³ãããŠããã å ¬è¡ã®äžå®ãã誀æ å ±ããšåãæšãŠãåŒ·å¶æ¥çš®ãæšãé²ããã®ã¯ãæåœã®ãããïŒ ãããšããå·šé¡ã®å©çãšæš©åç¶æã®ãããã
è¯ãæå³ãªãããªãããŒã¿ãéå ¬éã«ããååãã®é·æç ç©¶ãæ ã£ãã®ãïŒ æ ç»ã§ãææãããããã«ããã€ãªãã£ã¹ããªãã¥ãŒã·ã§ã³ã®å®å šæ§ããŒã¿ãé èœããçæãæµ®äžããFDAã¯2025幎8æã«EUAãæ€åããããåŸãªããªã£ãã åççãªçåãŸã§ãããåã¯ã¯ããšã¬ããã«è²ŒãããœãŒã·ã£ã«ã¡ãã£ã¢ã§æ€é²ãç¹°ãè¿ããã®ããéææ§ãæããããã ã
æ ç»ã§ç»å ŽããããŒã¿ãŒã»ããã«ããŒå士ããŸãã¯mRNAéçºè ã®ãããŒãã»ãããŒã³å士ãå¿èå°éå»ã®ã¢ã·ã ã»ãã«ããã©æ°ã®ããã«ãèŠåãçºããäžæµã®å°éå®¶ããæ²é»ããããããäºäŸãçžæ¬¡ãã ãæ±ºå®çãªã®ã¯ãè¢«å®³ã®æ¡å€§ãæããã«ãªã£ãä»ã§ãæ¥çš®ã¯ç¶ããŠããããšã ã ä»ã«ãç¡æ°ã®äºäŸãããããèªã¿åããæå³ã¯ãã¹ãŠã®æ¹åãåããŠãããããã¯å«çã®äŸå€èŠå®ãäºé广ã®ååãã«é©ããªããã®ã§ããã

4. åã®å¹æãæªãäžåããïŒ æ°åã®ããªãã¯
æå¹æ§ã¯çžå¯Ÿãªã¹ã¯äœæžã§95%ãšæŽŸæã«é³Žãããããã絶察å€ã§ã¯1%æªæºãå€ç°æ ªãåºãã°å¹æã¯æ¿æžããè¿œå æ¥çš®ã®ã«ãŒããçãã ãäžæ¹ãå¯äœçšã®æ»è ã¯å°æ°ãšã¯ãããè¥è ãå¥åº·ãªäººã§ã¯ãªã¹ã¯ãäžåãã±ãŒã¹ãå€ããå®äžçããŒã¿ã§ãä¿è·å¹æã®æžè¡°ãæããã«ãªããå©ç-ãªã¹ã¯æ¯ã厩ããŠããã2025幎ã®ã«ããå ¬è¡è¡çã¬ã€ãã©ã€ã³ã§ããã¯ã¯ãã³æšå¥šãæ éã«ãªãã察象ãçµã£ãŠãããæãããåœã倱ãããåœãäžåãïŒ ããã¯è©Šéšã®ãã€ã¢ã¹ãšé倧宣äŒã®ç£ç©ã ãäœãªã¹ã¯å±€ãåäŸãåŠå©Šã«ãŸã§æãããã®ã¯ãæ¯äŸæ§ãç¡èŠããæŽèµ°ã§ããã
ãäºé广ã®ååãã¯ãçŸããçè«ã ãã ããmRNAã¯ã¯ãã³ã®çŸå®ã§ã¯ãæ¡ä»¶ãæºããããã¯ã¯ãã³ãäŸå€æ±ãããå«ççåºç€ã¯å®å šã«å€±ãããŠããã
æ ç»ã®äžã§è¢«å®³è ã®æ¹ããæ¬åœã«å¹æã¯ãã£ãã®ãããšèªåããã·ãŒã³ããã£ããã圌ã®çåã¯å®å šã«æ£åœã§ããã广ããªãã£ãå Žåãäºé广ã®ååã¯åŽ©ããŠããŸãããã ã

åæã«èª€è§£ãæãå¯èœæ§ã®ããã»ãªãã§ããããšç§ã¯æãããã广ããã£ããšããã°ç ç²ã¯èš±ãããããšããèšå€ã®ãã¥ã¢ã³ã¹ãæããšããããããã ã
ãã®èšäºã§æ€èšããŠããããã«ãmRNAã¯ã¯ãã³ã¯ãå©çããæºãããŠãããšããŠãããã®ä»ã®ãäºé广ã®ååãã§ãããäžç«æ§ããæå³ããææ®µãã®ããããèŠä»¶ãæºãããŠããªãå¯èœæ§ã極ããŠé«ãããã ã
ããã¯ãå¥åº·ãªæ è¡è ãæ®ºããŠèåšãåé ããããšã§ã5人ã®åœãå©ãããšãã广ã100%確å®ã§ãã£ãŠãããããŠèš±ãããªãããšãšè«ççã«å矩ã§ããã

åå©äž»çŸ©ã®èªæïŒãªããæ°ã®èšç®ãã ãã§ã¯äžååãªã®ã
ãæå€§å€æ°ã®æå€§å¹žçŠãšããååã¯ãå人ã®å°å³ãæ°ã«éå ãããããŠèª°ããç ç²ã®åè£ã«ãªããã瀟äŒãäœãåºãã
ãåå©äž»çŸ©ãã®ç«å Žããããã°ããã¹ãŠã®ãããã³åé¡ã¯åçŽã ãåžžã«ããå€ãã®åœãæãéžæããã¹ãã§ãããããããç§ãã¡ã®é埳ççŽæã¯ããã®åçŽãªèšç®ã«æµæããã
äžã€ã®çç±ã¯ãåå©äž»çŸ©ããå人ã®å°å³ãã軜èŠããããã ãå¥åº·ãªæ è¡è ãæ®ºããŠèåšãåé ããããšã¯ããã®äººéããåãªãè³æºããšããŠæ±ãããšãæå³ãããã«ã³ãå«çåŠã匷調ããããã«ã人éã¯ããèªäœãšããŠç®çã§ãããæ±ºããŠåãªãææ®µãšããŠæ±ãããã¹ãã§ã¯ãªãã
ããäžã€ã®çç±ã¯ãåå©äž»çŸ©çæèã瀟äŒã«äžãããé·æç圱é¿ãã§ããããããããå€ããæããããªãå°æ°ãç ç²ã«ããŠè¯ãããšããååãå»çã®æšæºãšãªãã°ã誰ãããå°æ°ã®ç ç²ãã«éžã°ããææã®äžã§çããããšã«ãªããç é¢ã¯ä¿¡é Œã®å Žã§ã¯ãªããæœåšçãªè åšã®å Žãšãªãã
èŠååå©äž»çŸ©ã¯ããã®åé¡ãèªèããããå¥åº·ãªäººã殺ããŠèåšãåé ããããšããè¡çºãäžè¬åããããšã¯æ¥µç«¯ã«èããããããããªããããããæŽå²ãæ¯ãè¿ãã°ãåå©äž»çŸ©çå«çãæ®µéçã«åºãããæåã¯ãäŸå€çç¶æ³ããšããããã®ã次第ã«åžžæ åããŠããéçšãç®æã§ããã
ããã¹ã®T4ããã°ã©ã ã¯ããçç£æ§ã®ãªãçåœã¯ç€ŸäŒè³æºã®æµªè²»ããšããåå©äž»çŸ©çè«çããå§ãŸã£ããæåã¯ãé床é害è ã®ã¿ããšããéå®çãªå¯Ÿè±¡ã ã£ããããããŠã瀟äŒã«æçšã§ãªãè ãå šè¬ãžãšæ¡å€§ããããã³ãŒã¹ããžã®éãéããã
ã¿ã¹ãã®ãŒæ¢ æ¯å®éšãããå»åŠã®é²æ©ãšãã倧ããªå©çã®ããã«ãå°æ°ã®ç¡ç¥ãªè¢«éšè ã䜿ãããšããåå©èšç®ã®ç£ç©ã ã£ãã

ãŸããåå¥ã®ã±ãŒã¹ã§ã¯ã5人ãæãããã«1人ãç ç²ã«ãããããšãæ£åœåãããŠãããããèŠåãšããŠæ¡çšãããã°ãå»çã«ãããä¿¡é Œã¯åŽ©å£ãããã仿¥ã¯ç§ãæãããåŽãããããªãããææ¥ã¯ç ç²ã«ãããåŽã«ãªããããããªãããšããææãã人ã ãç é¢ããé ãããå»çã·ã¹ãã å šäœãæ©èœäžå šã«é¥ããé·æçã«ã¯ãåå©äž»çŸ©ç倿ãçæçã«æã£ãåœããããã¯ããã«å€ãã®åœã倱ãããããšã«ãªãã
ããã¯éå±å®³ååã®æè·ã«ç¹ãããããŸã害ããªããªããšããååãå»çã®åºæ¬èŠåãšããããšã¯ãå«ççãªååãšããŠã ãã§ã¯ãªããé·æçã«èŠãã°æãå€ãã®äººã ã«å©çãããããåå©äž»çŸ©çãªèŠç¹ãååšããã
ããã¯ã©ãã¹ã®æä»£ããç¶ããã®å«çã¯ãåãªãé埳ç説æã§ã¯ãªããçŽå å5äžçŽã®èªãã¯ãæ®èãªæ²»çãæåŠããåçºããçãŸããéå±å®³ã®ååãå®ããã 2025幎çŸåšããWHOã¬ã€ãã©ã€ã³ã§ããããåºç€ãšãªããåå©ã®æŽèµ°ãæ³çã«å°ããå®è·µçãªçŸã ãæŽå²ã®è¡å¡ãã®æèšããå人ã®å°å³ãå®ãçŸãéãäžããã¯ãã ã£ãâãããŠãæ®å¿µãªããã³ãããã³ãããã¯ã§ã¯ããã®å«çã®çŸãåã³ç ŽãããŠããŸã£ãã®ã§ããã
å»åž«ã®äœ¿åœãšã¯äœãïŒæè¡è ãããããšãå®è·è ã
ãå»åž«ã¯ç€ŸäŒã®ä»£ç人ã§ã¯ãªããç®ã®åã®æ£è ã®ä»£ç人ã§ããã
æ ¹æ¬çãªåãã«ç«ã¡è¿ããââå»åž«ãšã¯äœè ãªã®ãïŒ
ããå»åž«ãåãªãå»çæè¡ã®æäŸè ã§ããããã®ç®çãã瀟äŒå šäœã®å¥åº·ææšã®æå€§åãã§ãããªãããªã¹ã¯ãããã£ããè«ã¯æ£åœåããããããããªããããããäŒçµ±çãªå»çå«çãæ³å®ããå»åž«åã¯ç°ãªãã
å»åž«ã¯ç®ã®åã®æ£è ã®å®è·è ã§ãããæ£è ãå»åž«ã«èº«ãå§ããã®ã¯ãå»åž«ããç§ã®æåã®å©çãå³ã£ãŠãããããšä¿¡é Œããããã ããã®ä¿¡é Œé¢ä¿ã¯ã瀟äŒå šäœã®å©çã®ããã«æ£è ãç ç²ã«ããå¯èœæ§ãšäž¡ç«ããªãã

ããæ£è ãããã®å»åž«ã¯ãå Žåã«ãã£ãŠã¯ç§ã5人ã®ããã«ç ç²ã«ãããããããªãããšçãã°ãå»çã«ãããä¿¡é Œã¯åŽ©å£ãããéå±å®³ååã¯ããŸãã«ãã®ä¿¡é Œãå®ãããã®èªçŽãªã®ã ã
ãç§ã¯ããªãã«å®³ãå ããªãããšããçŽæã¯ããç§ã¯ããªããä»ã®èª°ãã®ããã®ææ®µãšããŠæ±ããªãããšããæå³ãå«ãã§ããã
è¿å¹Žã®å»çã®çµæžåãšå®ååã¯ããã®äœ¿åœãèŠå€±ãããŠãããå»åž«ã¯ãæ£è ã®å®è·è ãããå»çã·ã¹ãã ã®å¹çç管çè ããžãšåœ¹å²ãå€ãã€ã€ããããªã¹ã¯ãããã£ããè«ãå»çå°éå®¶ã®å£ããèªãããããã«ãªã£ãã®ã¯ããŸãã«ãã®ãå»çã®è±äººæ Œåãã®åž°çµã§ããã
ããŸãã害ããªããªãã
ã"primum non nocere"ïŒãŸã害ããªããªããïŒã®"primum"ïŒãŸãïŒãšããèšèã¯ãåãªãæéçé åºã§ã¯ãªãã䟡å€ã®åºåã瀺ããŠããã
ããã¯ã©ãã¹ã®èªãââããŸã害ããªããªãããïŒprimum non nocereïŒââã«ãããŠãæãéèŠãªåèªã¯ããŸãããããããªãã

ãã®èšèã¯ãéå±å®³ãæéçã«æåã§ããã ãã§ãªãã䟡å€ã®åºåã«ãããŠæåªå ã§ããããšã瀺ããŠãããä»ã®ãã¹ãŠã®å«ççèæ ®ã¯ããã®ç¬¬äžååã䟵害ããªãç¯å²ã§ã®ã¿è¿œæ±ãããã¹ãã ã
ãããããªã¹ã¯ãããã£ããè«ã§ã¯ããã®ããŸãããæ¶ããŠãããããªã¹ã¯ãšãããã£ããã倩秀ã«ãããããšãã衚çŸã¯ã害ãšå©çã察çãªèŠçŽ ãšããŠæ¯èŒãããããšãæå³ããã害ãé¿ããããšã«ç¹å¥ãªåªå æ§ã¯ãªãã
ããã¯ãå»çå«çã®æ ¹æ¬ç転æã§ãããéå±å®³ã¯ããã¯ãããŸããå®ãããã¹ãååã§ã¯ãªããä»ã®å€ãã®èæ ®äºé ã®ãäžã€ãã«éããªããªãã
ãã€ãŠå»åž«ã¯ãç§ã¯ãã®æ£è ã«å®³ãåãŒããªãã ãããããšèªåãããä»ã§ã¯ããªã¹ã¯ãšãããã£ããã®ãã©ã³ã¹ã¯ã©ããããšåããåè ã¯å®³ã®åé¿ãåºçºç¹ãšãããåŸè ã¯æé©åãç®æšãšããããã®éãã¯åŸ®åŠã ãæ±ºå®çã ãã
倱ãããå«çã®ç·åŒµïŒåãç¶ããããšã®æå³
ãããã³åé¡ã®è«žå€åœ¢ã¯ãå®ç§ãªçããäžããªããæ®ºãããšãšæ»ãªããããšã®å¢çã¯ææ§ã ãæå³ãšäºèŠã®åºå¥ããåžžã«æç¢ºã§ã¯ãªãããããããã®ææ§ãããã®æºããããããå«ççå€æã®æ¬è³ªãªã®ãããããªãã
å»çå«çã«ãããŠçµ¶å¯Ÿçãªå ¬åŒã¯ãªããéå±å®³ååããæèã®äžã§ãä»ã®ååãšã®ç·åŒµã®äžã§ãåžžã«åè§£éããç¶ããªããã°ãªããªããéèŠãªã®ã¯ããã®ç·åŒµãæãç¶ããããšã ã
æ¬æ¥ããã®ãããªç·åŒµæã®äžã§ãè«ççãªèå¯ãè¡ã声ããããããšãããçåœå«çåŠè ã®ä»äºã®ã¯ãã ããç§ã®ç¥ãéãæ¥æ¬ã§ã¯çç¡ã ã£ããããã¯ç€ŸäŒã®å«çåºç€ãã®ãã®ãæªãã§ããâãšæžãã®ã¯èšãéãã ãããã
ããªã¹ã¯ãããã£ãããèšç®ããã°çãã¯æçœããšèšãå»åž«ããã¯ããã®ç·åŒµãæããããªãã圌ãã¯ãå«ççãžã¬ã³ããæè¡çåé¡ã«éå ããŠããŸã£ãŠããããããã5人ãæãããã«1人ãç ç²ã«ãã¹ãããšããåãã¯ãæè¡çåé¡ã§ã¯ãªããããã¯ã人éã®å°å³ãšã¯äœããå»çãšã¯äœããç§ãã¡ã¯ã©ã®ãããªç€ŸäŒã«çãããã®ããšããæ ¹æ¬çãªåããªã®ã ã

- #mRNAã¯ã¯ãã³
- #ãããã³åé¡
- #å»çå«ç
- #çåœå«ç
- #ã€ã³ãã©ãŒã ãã³ã³ã»ã³ã
- #å«ççãžã¬ã³ã
- #ããã¯ã©ãã¹ã®èªã
- #ããã¯ã©ãã¹ã®ç²ç¹
- #æ£è ã®å°å³
- #å»çå²åŠ
- #ã«ã³ãå«çåŠ
- #åå©äž»çŸ©æ¹å€
- #å»çã®äººéå
- #éå±å®³åå
- #ãªã¹ã¯ãããã£ããè«
- #ãã³ãããã¯å«ç
- #äºé广ã®åå
- #éå 害ã®åå
- #ç¡å 害ã®åå